FDA Clears Expanded Indications for Swift Microwave Wart Device
New data show the Swift system reduces blistering, discomfort, and recovery time while maintaining strong clinical outcomes for common and plantar warts.
New data show the Swift system reduces blistering, discomfort, and recovery time while maintaining strong clinical outcomes for common and plantar warts.
Expanded clearance allows the system to support hair removal and vascular lesion treatment using multiple wavelength configurations.
The device uses 2.45-GHz energy and three handpieces designed to target subcutaneous tissue while maintaining surface cooling, according to the company.